Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations

被引：0
作者：
Federica Perrone
Maria Bjerke
Elisabeth Hens
Anne Sieben
Maarten Timmers
Arne De Roeck
Rik Vandenberghe
Kristel Sleegers
Jean-Jacques Martin
Peter P. De Deyn
Sebastiaan Engelborghs
Julie van der Zee
Christine Van Broeckhoven
Rita Cacace
机构：
[1] Neurodegenerative Brain Diseases Group,Department of Biomedical Sciences
[2] VIB Center for Molecular Neurology,Reference Centre for Biological Markers of Dementia (BIODEM), Institute Born
[3] Institute Born-Bunge,Bunge
[4] University of Antwerp,Laboratory of Neurochemistry and Center for Neurosciences
[5] University of Antwerp,Department of Neurology and Memory Clinic
[6] UZ Brussel and Vrije Universiteit Brussel,Department of Neurology
[7] Hospital Network Antwerp,Department of Neurology
[8] Middelheim and Hoge Beuken,Department of Neurology
[9] University Hospital Antwerp,Department of Neurosciences, Faculty of Medicine
[10] University Hospital Brussel and Center for Neurosciences,Laboratory of Cognitive Neurology, Department of Neurology
[11] Vrije Universiteit Brussel,undefined
[12] University Hospital Ghent and University of Ghent,undefined
[13] Janssen Research and Development,undefined
[14] Division of Janssen Pharmaceutica NV,undefined
[15] KU Leuven,undefined
[16] University Hospitals Leuven,undefined
来源：
Alzheimer's Research & Therapy | / 12卷
关键词：
Alzheimer’s disease (AD); Amyloid-β 1–43 (Aβ; ); Cerebrospinal fluid (CSF); Alzheimer mutations; Oxford Nanopore Technologies (ONT) long-read sequencing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 251 条
[1]  
Cruchaga C(2018)Polygenic risk score of sporadic late-onset Alzheimer’s disease reveals a shared architecture with the familial and early-onset forms Alzheimer’s Dement 14 205-214
[2]  
Del-Aguila JL(2008)Molecular genetics of Alzheimer’s disease: an update Ann Med 40 562-583
[3]  
Saef B(2016)Familial Alzheimer’s disease mutations in presenilin generate amyloidogenic Aβ peptide seeds Neuron Cell Press 90 410-416
[4]  
Black K(2012)National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease Alzheimers Dement 8 1-13
[5]  
Fernandez MV(2017)Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase Proc Natl Acad Sci U S A 114 E476-E485
[6]  
Budde J(2013)Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE Am J Pathol Am J Pathol 182 2322-2331
[7]  
Brouwers N(2014)Characterization of intermediate steps in amyloid beta (Aβ) production under near-native conditions J Biol Chem 289 1540-1550
[8]  
Sleegers K(2015)Diagnostic accuracy of cerebrospinal fluid amyloid-β isoforms for early and differential dementia diagnosis J Alzheimer’s Dis 45 813-822
[9]  
Van Broeckhoven C(2003)Decreased β-amyloid JAMA 289 2094-2103
[10]  
Veugelen S(2006) and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease Ann Neurol 59 512-519
12345678910